Durham drugmaker Chimerix names new CEO at pivotal time

After selling its smallpox treatment for hundreds of millions of dollars, Chimerix is undergoing a leadership transition as it focuses on developing a new drug.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news